Corrigendum to “eNose analysis for early immunotherapy response monitoring in non-small cell lung cancer” [Lung Cancer 160 (2021) 36–43]

The authors regret that absolute sensor differences were not calculated “by subtracting sensor values measured after six weeks of treatment from sensor values measured at baseline for each sensor”, as mentioned in the “Statistical analysis” section, page 3 of the Supplementary appendix, but “by subtracting sensor values measured at baseline from sensor values measured after six weeks of treatment for each sensor”.

Source: Lung Cancer - October 22, 2021 Category: Cancer & Oncology Authors: Alessandra I.G. Buma, Mirte Muller, Rianne de Vries, Peter J. Sterk, Vincent van der Noort, Marguerite Wolf-Lansdorf, Niloufar Farzan, Paul Baas, Michel M. van den Heuvel Tags: Corrigendum Source Type: research